TechCrunchVineti to fast-track cell and gene therapy tech with $14 million first …Healthcare IT NewsSan Francisco-based Vineti, a cell and gene therapy software and analytics company, has closed on Series A funding round that pulled together nearly $… Continue reading
News-Medical.netInternational team to set how gene therapies in hemophilia should be measured for effectivenessNews-Medical.netAn international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are … Continue reading
Morung ExpressGrape extracts may protect against colon cancerMedical News TodayA team of researchers led by Jairam K. P. Vanamala, associate professor of food sciences at the College of Agricultural Sciences at Pennsylvania State University in State Co… Continue reading
Business Insider |
This startup wants to regenerate the heart and brain to keep people healthier for longer
Business Insider That means that the stem–cell therapies have to be converted into whatever cell they’re meant to be (heart-muscle cells, neurons, and so forth) before going into the body, rather than using different kinds of stem cells to treat the condition. And the … |
|
Cynata Therapeutics Files New Patent Application for Cymerus™ Stem Cell Technology in Oncology
Nasdaq MELBOURNE, Australia, June 20, 2017 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today that the Company has filed a new patent application with IP Australia for … |
|
Cynata Therapeutics Files New Patent Application for Cymerus™ Stem Cell Technology in Oncology
Nasdaq MELBOURNE, Australia, June 20, 2017 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today that the Company has filed a new patent application with IP Australia for … |
|
Cynata Therapeutics Files New Patent Application for Cymerus™ Stem Cell Technology in Oncology
GlobeNewswire (press release) MELBOURNE, Australia, June 20, 2017 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today that the Company has filed a new patent application with IP Australia for … |
Bioscience Technology |
Firefly Gene Illuminates Ability of Optimized CRISPR-Cpf1 to Efficiently Edit Human Genome
Bioscience Technology Professor Michael Farzan, co-chair of TSRI’s Department of Immunology and Microbiology, and TSRI Research Associate Guocai Zhong improved the efficiency of the CRISPR-Cpf1 gene editing system by incorporating guide RNAs with “multiplexing” … |